Harris Associates
COV

Harris Associates’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Harris Associates’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-576,586
Closed -$59M – 190
2014
Q4 		$59M Sell
576,586
-194,357
-25% -$18.6M 0.09% 102
2014
Q3 		$66.7M Sell
770,943
-258,847
-25% -$22.9M 0.11% 101
2014
Q2 		$92.9M Sell
1,029,790
-2,660,601
-72% -$199M 0.16% 92
2014
Q1 		$272M Buy
3,690,391
+14,592
+0.4% +$1.02M 0.49% 65
2013
Q4 		$250M Sell
3,675,799
-682
-0% -$44.4K 0.45% 64
2013
Q3 		$224M Sell
3,676,481
-379,197
-9% -$23.1M 0.44% 67
2013
Q2 		$226M Buy
+4,055,678
New +$235M 0.47% 69

Harris Associates's COV Position: Q1 2015 in Review

Harris Associates sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 576,586 shares — an estimated $59M sold.

Harris Associates first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $272M in Q1 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Harris Associates reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Harris Associates sold 576,586 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $59M.
  • Harris Associates first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Harris Associates's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $272M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Harris Associates's 13F filing for Q1 2015, filed 14 May 2015.